Jennifer Van Brunt, Editor


November 19, 2008


Déjà vu All Over Again
Déjà vu All Over Again

Where did the first agricultural biotech field trial take place?



A rotating collection of articles from Signals’ archives on selected topics of interest.

A handy guide that tracks recent name changes in the biotech sector.



NEWS LINKS


Signals Magazine
is published by
Recap.com





A new way to explore & understand biotech intellectual property. Patents & patent applications, linked to their commercial agreements, reveal a world of 'partnered IP' that has been inaccessible until now.





A collection of material from Recap's consultants, including slide presentations, trend analyses, alliance discussions and much more.



20 Compounds That Defined Biotech
In celebration of Recombinant Capital’s 20th year, we are recounting the storied history of 20 biologics that helped to define biotechnology – and continue to do so.

Much Ado About Biologics
Most big pharmas have been slowly building their stores of protein- and antibody-based medicines, but they picked up the pace in 2007 with a series of clever acquisitions.

FDA Deals Biotech A Winning Hand
While it’s true that product approvals lagged last year, the FDA still gave the nod to a number of important new drugs, biologics and vaccines – including two new classes of AIDS drugs and three more targeted cancer therapies. Nearly half of them have biotech origins.



© 2008 Signals Magazine